Exclusive: OxyContin maker Purdue is ‘Pharma Co X’ in U.S. opioid kickback probe – sources

Exclusive: OxyContin maker Purdue is ‘Pharma Co X’ in U.S. opioid kickback probe – sources
NEW YORK (Reuters) – OxyContin maker Purdue Pharma LP is the unnamed company that surfaced in criminal charging documents filed earlier this week in a probe of illegal kickbacks from drugmakers, according to people familiar with the matter. FILE PHOTO: Bottles of prescription painkiller OxyContin pills, made by Purdue Pharma LP sit on a counter at a local pharmacy in... Read More

Coronavirus infects Asia stocks with exposure to China

Coronavirus infects Asia stocks with exposure to China
SYDNEY (Reuters) – Shares of companies highly exposed to China’s economy tumbled across Asia on Tuesday on rising concern about the impact of global travel bans associated with a new virus outbreak, and even as some stocks involved in preventative health spiked. FILE PHOTO: Investors look at computer screens showing stock information at a brokerage house in Shanghai, China January... Read More

New York, FTC sue ‘pharma bro’ Shkreli, others over Daraprim price hikes

New York, FTC sue ‘pharma bro’ Shkreli, others over Daraprim price hikes
FILE PHOTO: Former drug company executive Martin Shkreli exits U.S. District Court after being convicted of securities fraud, in the Brooklyn borough of New York City, U.S., August 4, 2017. REUTERS/Carlo Allegri/File Photo WASHINGTON (Reuters) – Martin Shkreli, the “pharma bro” in prison for defrauding investors, faces a lawsuit filed by the Federal Trade Commission and New York Attorney General’s... Read More

Trump’s ‘massive’ U.S.-UK trade deal faces big hurdles

Trump’s ‘massive’ U.S.-UK trade deal faces big hurdles
WASHINGTON (Reuters) – Britain is the United States’ closest ally but their long friendship may be sorely tested as the two countries try to forge a new trade agreement after Britain’s exit from the European Union. FILE PHOTO: Britain’s Prime Minister Boris Johnson welcomes U.S. President Donald Trump at the NATO leaders summit in Watford, Britain December 4, 2019. REUTERS/Peter... Read More

AbbVie-Allergan $63 billion deal aided by Nestle, AstraZeneca buys

AbbVie-Allergan $63 billion deal aided by Nestle, AstraZeneca buys
ZURICH (Reuters) – U.S. drugmaker AbbVie’s (ABBV.N) $63 billion tie-up with Allergan (AGN.N) is getting help from Nestle (NESN.S) and AstraZeneca (AZN.L) buying up products the Irish-domiciled company is shedding to placate regulators. FILE PHOTO: The Allergan logo is seen in this photo illustration November 23, 2015. To match special report USA-FDA/CASES REUTERS/Thomas White AbbVie is swallowing Allergan to give... Read More

Exclusive: U.S. pushing India to buy $5-6 billion more farm goods to seal trade deal – sources

Exclusive: U.S. pushing India to buy $5-6 billion more farm goods to seal trade deal – sources
NEW DELHI (Reuters) – The United States wants India to buy at least another $5-6 billion worth of American farm goods if New Delhi wants to win reinstatement of a key U.S. trade concession and seal a wider pact, four sources familiar with the talks told Reuters. FILE PHOTO: A man holds the flags of India and the U.S. while... Read More

Exclusive: U.S. pushes India to buy $5-6 billion more farm goods to seal trade deal – sources

Exclusive: U.S. pushes India to buy $5-6 billion more farm goods to seal trade deal – sources
NEW DELHI (Reuters) – The United States wants India to buy at least another $5-6 billion worth of American poultry and farm goods if New Delhi wants to win reinstatement of a key U.S. trade concession, four sources familiar with the talks told Reuters. FILE PHOTO: A man holds the flags of India and the U.S. while people take part... Read More

Bayer faces fourth U.S. Roundup cancer trial in Monsanto’s hometown

Bayer faces fourth U.S. Roundup cancer trial in Monsanto’s hometown
(Reuters) – Bayer AG (BAYGn.DE) is set to face a fourth U.S. jury trial over allegations that its Roundup weed killer causes cancer, with four cancer patients in the hometown of its agricultural subsidiary Monsanto scheduled to begin making their case on Friday. The lawsuit marks the first multi-plaintiff trial in the litigation over whether glyphosate, Roundup’s active ingredient, is... Read More

Insys founder Kapoor sentenced to 66 months in prison for opioid scheme

Insys founder Kapoor sentenced to 66 months in prison for opioid scheme
BOSTON (Reuters) – John Kapoor, the founder of Insys Therapeutics Inc (INSYQ.PK), on Thursday was sentenced to 66 months in prison for his role in a bribery and fraud scheme that contributed to the U.S. opioid crisis. FILE PHOTO: John Kapoor (R), the billionaire founder of Insys Therapeutics Inc., leaves the federal courthouse during the trial accusing Insys executives of... Read More